Flora Peyvandi, Italy
The early response to an overwhelming epidemic, and the early treatment adaptations, e.g., with respect to thrombosis and anticoagulation
Flora Peyvandi is professor of Internal Medicine at the University of Milan, Italy and director of the Angelo Bianchi Bonomi Hemophilia and Thrombosis Center at Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milan, Italy.
Dr. Peyvandi received her medical degree from the University of Milan, Italy and is certified in Haematology. She earned her PhD from the Maastricht University, The Netherlands for her research in the field of rare bleeding disorders. She was research fellow at the Royal Free Hospital, University College London, London, UK in 1997-98 for molecular characterisation of rare bleeding disorders and at the Veteran’s Administration Hospital, Harvard University, Boston, USA in 1998-99 for in vitro expression studies on novel gene variants in clotting disorders.
Dr. Peyvandi is dedicated to bringing state-of-the-art treatments and technologies to her research program and to offering patients the most novel therapeutic approaches available. Her research has been focused on the investigation of prevalence and mechanism of coagulation disorders and on the immunogenicity of coagulation products. She has participated for many years in educational and research activities of scientific societies and patients’ organizations, such as ISTH, EAHAD, WFH and EHC. She is currently president-elect of the International Society of Thrombosis and Haemostasis and president of the European Association for Haemophilia and Allied Disorders. She also serves on the Technical Health Committee of the Italian Ministry of Health.
Most recently, Dr. Peyvandi has focused on the management of hemostatic alterations in COVID-19 patients.